Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 24 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 11 Lung Neoplasms 11 Neoplasm Metastasis 10 Carcinoma, Hepatocellular 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Triple Negative Breast Neoplasms 7 Advanced Solid Tumors 7 Melanoma 6 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Cholangiocarcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Renal Cell 4 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Head and Neck Neoplasms 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Advanced Solid Tumours 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Solid Tumor 2

Interventions

durvalumab 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally Advanced Rectal Carcinoma × durvalumab × Clear all

NCT06304597 2024-03-12

PREDICT

University Medical Center Groningen

Phase 1 Unknown

Gastrointestinal

Locally Advanced Rectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡